A new biosensor for detecting HIV and Hepatitis viruses in low-resource areas
A single biosensors for the simultaneous molecular detection of HIV and Hepatitis B and C viruses at resource-limited settings
This study is working on a new, easy-to-use test that can quickly check for HIV, Hepatitis B, and Hepatitis C all at once, especially in places where medical resources are limited, to help more people get diagnosed and treated sooner.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Central Florida NIH-funded |
| Lab location | 1 site (Orlando, United States) |
| Project ID | NIH-11187332 on NIH RePORTER |
What this research studies
This research focuses on developing a novel electrochemical biosensor that can simultaneously detect HIV, Hepatitis B (HBV), and Hepatitis C (HCV) viruses. The approach utilizes advanced technology involving four-way junction probes and isothermal amplification techniques, making it suitable for use in resource-limited settings. By improving diagnostic capabilities, this research aims to address the high rates of undiagnosed and untreated cases of these viruses, particularly in hard-to-reach populations. The goal is to enhance patient outcomes by facilitating earlier diagnosis and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in resource-limited settings who are at risk for or currently infected with HIV, HBV, or HCV.
Not a fit: Patients who are not at risk for these infections or who are already receiving effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the early detection and treatment of HIV and Hepatitis infections, leading to better health outcomes for affected individuals.
How similar studies have performed: Previous research has shown promise in developing biosensors for viral detection, indicating that this approach could lead to significant advancements in diagnostics.
Where this research is happening
Orlando, United States
- University of Central Florida — Orlando, United States (Active)
Researchers
- Principal investigator: Chumbimuni-Torres, Karin — University of Central Florida
- Study coordinator: Chumbimuni-Torres, Karin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.